Marina Feřtek, Pharm.Dr.

Marina obtained her Pharm.Dr. degree in the field of molecular biology from the Faculty of Pharmacy in the Czech Republic. After spending time as a research scientist in a biotech company in Denmark, Marina has joined the Czech Medicines Agency as an assessor of the clinical studies for marketing authorisations. She specialized in complex developments and as part of the CHMP procedures team, Marina assessed the pharmacokinetic data of the new active substances and other innovative dosage forms. She participated in EMA pharmacokinetics working group, where specific PK-related problems and new guidelines were being discussed.

As an independent consultant Marina has performed clinical dossier audits of several non-EU developments, has prepared briefing books for national and EMA scientific advice, and has responded to numerous clinical queries in the frame of the marketing authorisation procedures.

In collaboration with other experts, Marina participates in the development of the regulatory landscape of the emerging markets, namely on the African continent. She has performed assessor´s training there and has shared her European regulatory experience with African regulators.